Cargando…
CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung Adenocarcinoma
Given that, even after multimodal therapy, early-stage lung cancer (LC) often recurs, novel prognostic markers to help guide therapy are highly desired. The mRNA levels of cell division cycle 25C (CDC25C), a phosphatase that regulates G2/M cell cycle transition in malignant cells, correlate with poo...
Autores principales: | Stern, Esther, Pines, Guy, Lazar, Li Or, Vainer, Gilad W., Beltran, Nitzan, Dodi, Omri, Gamaev, Lika, Hikri Simon, Ofir, Abraham, Michal, Wald, Hanna, Peled, Amnon, Wald, Ori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952919/ https://www.ncbi.nlm.nih.gov/pubmed/36830899 http://dx.doi.org/10.3390/biomedicines11020362 |
Ejemplares similares
-
Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth
por: Beider, Katia, et al.
Publicado: (2009) -
Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis
por: Karlsson, Christina, et al.
Publicado: (1999) -
Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression
por: Kirshberg, Sophie, et al.
Publicado: (2011) -
Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics
por: Stern, Esther, et al.
Publicado: (2023) -
Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation
por: Abraham, Michal, et al.
Publicado: (2017)